Precigen Inc. (PGEN)

[skitahoe]

I'm not currently a shareholder, but I do have some GNVC which should eventually become XON. When I look at what people are saying here, no one seems to care about the GNVC acquisition.

XON to me looks almost more like a mutual fund than a stock, as it's comprised of many very dissimilar companies. It's different from anything I've invested in before, but it's my intention to hold GNVC at least until the time it becomes XON, or they cancel the deal.

For the longest time you could multiply the XON price by .297 and arrive at nearly GNVC's price, normally just a few pennies higher. Recently it seems that even greater value is being given to GNVC, which seems to indicate that their is a growing belief that Novartis will pay at least the $5 million milestone for starting a Phase 2B Trial with the hearing drug in the 36 months after the acquisition by XON, this will equate to a little over $1 per GNVC shareholders at the time of the acquisition.

On occasions I've actually seen GNVC at less than .297 X XON. If I were interested in holding XON, I'd look to buy GNVC when it's priced that way. I believe the odds are at least even that you'll see that Novartis payment, and I believe that long term the hearing drug may prove one of XON's greatest assets.

Gary